MARKET

PACB

PACB

PacBio
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.25
+0.34
+3.82%
After Hours: 9.25 0 0.00% 19:52 09/25 EDT
OPEN
8.90
PREV CLOSE
8.91
HIGH
9.26
LOW
8.73
VOLUME
4.13M
TURNOVER
--
52 WEEK HIGH
9.26
52 WEEK LOW
2.200
MARKET CAP
1.61B
P/E (TTM)
-27.8112
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
The Daily Biotech Pulse: Novavax Advances Vaccine, Marinus Gets Nod For Late-Stage Study, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 24)
Benzinga · 1d ago
The Daily Biotech Pulse: Gilead's $7.25B Debt Offering, Lexicon Deleverages, Taysha Gene Therapies Prices IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 23)
Benzinga · 2d ago
New Leadership Driving New Interest In Pacific Biosciences
Pacific Biosciences' new CEO Christian Henry has made it clear that he intends to drive significant investment in the company's commercialization efforts.Strategic partnerships could be an underappreciated opportunity and a "force multiplier" for Pacific Biosciences' commercialization efforts, particularly if a company like Illumina or Thermo Fisher comes into the picture.Pacific Biosciences still has yet to make the difficult transition from an R&D company to a viable commercial enterprise, but Henry looks like a good choice to lead that process.
Seekingalpha · 3d ago
Pacific Biosciences (PACB) Looks Good: Stock Adds 5.3% in Session
Pacific Biosciences (PACB) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Zacks · 3d ago
The Daily Biotech Pulse: Coronavirus Vaccine Updates From J&J & MediciNova, Australian Regulatory Nod For GW Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22)
Benzinga · 3d ago
The Daily Biotech Pulse: Legal Relief For Evolus, Fulgent to Join S&P SmallCap 600, AIM ImmunoTech's Positive Cancer Drug Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 21)
Benzinga · 4d ago
Pacific Biosciences' Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor Pacific Biosciences of California.
Zacks · 4d ago
The Daily Biotech Pulse: Moderna Inks 2 R&D Deals, BioNTech To Buy Manufacturing Facility, Dyne Therapeutics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16)
Benzinga · 09/17 11:59
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PACB. Analyze the recent business situations of PacBio through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PACB stock price target is 7.25 with a high estimate of 11.00 and a low estimate of 5.00.
EPS
Institutional Holdings
Institutions: 226
Institutional Holdings: 118.61M
% Owned: 68.26%
Shares Outstanding: 173.75M
TypeInstitutionsShares
Increased
47
11.20M
New
49
-3.77M
Decreased
38
13.25M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.83%
Healthcare Equipment & Supplies
+2.01%
Key Executives
Chairman/Independent Director
John Milligan
President/Chief Executive Officer/Director
Christian Henry
Chief Financial Officer
Benjamin Gong
Lead Director/Independent Director
Bill Ericson
Chief Accounting Officer/Vice President
Eric Schaefer
Vice President
Chris Seipert
Vice President
Denis Zaccarin
Director
Michael Hunkapiller
Director
Kathy Ordonez
Independent Director
David Botstein
Independent Director
William Ericson
Independent Director
Randall Livingston
Independent Director
Marshall Mohr
Independent Director
Lucy Shapiro
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About PACB
Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Pacific Biosciences of California Inc stock information, including NASDAQ:PACB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PACB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PACB stock methods without spending real money on the virtual paper trading platform.